• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Alvotech

< Previous 1 2 3 4 5 Next >
News headline image
Alvotech and Dr. Reddy’s Announce FDA acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®
March 18, 2025
From Alvotech
Via GlobeNewswire
Tickers ALVO RDY
News headline image
Alvotech Meeting Investors and Participates in Fireside Chat At Barclays 27th Global Healthcare Conference in Miami, Florida
March 07, 2025
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab)
January 27, 2025
From Alvotech
Via GlobeNewswire
Tickers ALVO TEVA
News headline image
Alvotech Added to Nasdaq Biotech Index Effective Monday December 23, 2024
December 23, 2024
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech Reports Financial Results for the First Nine Months of 2024
November 13, 2024
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech Attending Citi's Global Healthcare Conference on December 4, 2024, and Evercore’s HealthCONx Conference on December 5, 2024
November 07, 2024
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
European Medicines Agency Confirms Acceptance of Marketing Authorization Application for AVT05, a Proposed Biosimilar to Simponi® (golimumab)
November 04, 2024
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech to Report Financial Results for the First Nine Months of 2024 on November 13, 2024, and Host Conference Call on November 14, 2024, at 8:00 am ET
October 30, 2024
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech Meeting Investors and Presenting at the Jefferies 2024 London Healthcare Conference on November 19–20, 2024
October 25, 2024
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
European Medicines Agency Confirms Acceptance of Marketing Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®
October 10, 2024
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech Initiates Confirmatory Patient Study for AVT16, a Proposed Biosimilar to Entyvio®
September 25, 2024
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
August 26, 2024
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of 2024
August 15, 2024
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
European Medicines Agency Confirms Acceptance of Marketing Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)
August 15, 2024
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech to Report Financial Results for the First Half of 2024 on August 15, 2024, and Host Conference Call on August 16, 2024, at 8:00 am ET
August 01, 2024
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
STADA and Alvotech launch Uzpruvo, the first approved ustekinumab biosimilar to Stelara, across Europe
July 22, 2024
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech Announces Closing of Private Debt Financing
July 11, 2024
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech Announces Positive Topline Results from Confirmatory Patient Study for AVT03, a Proposed Biosimilar for Prolia® and Xgeva®
July 02, 2024
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech Issues New Shares to Holders of Convertible Bonds
July 01, 2024
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech Announces Record Preliminary Results for Revenues and EBITDA for the Second Quarter of 2024
July 01, 2024
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech Receives Conversion Notices for Majority of Convertible Bonds
June 26, 2024
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech and Advanz Pharma Sign Commercialization Agreement for Proposed Biosimilar to Eylea® LD/HD in Europe
June 18, 2024
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech and STADA add to strategic alliance through denosumab partnership
June 11, 2024
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech Announces Strategic Refinancing Agreement
June 07, 2024
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech to Participate in Jefferies Healthcare Conference in New York, June 5-6, 2024
May 29, 2024
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech Reports Financial Results for First Quarter of 2024 and Provides a Business Update
May 21, 2024
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech and Dr. Reddy’s enter into collaboration for commercialization of AVT03 (denosumab), a biosimilar candidate to Prolia® & Xgeva® in the U.S., Europe and UK
May 21, 2024
From Alvotech
Via GlobeNewswire
Tickers ALVO RDY
News headline image
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
May 20, 2024
From Alvotech
Via GlobeNewswire
Tickers ALVO TEVA
News headline image
Alvotech Announces Webcast of First Quarter 2024 Financial Results on May 22, 2024, at 8:00 am EDT (12 noon GMT)
May 13, 2024
From Alvotech
Via GlobeNewswire
Tickers ALVO
News headline image
Alvotech Announces Participation at BofA Securities Healthcare Conference 2024
May 02, 2024
From Alvotech
Via GlobeNewswire
Tickers ALVO
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap